Skip to main content
Clinical Trials/NCT03086187
NCT03086187
Completed
Not Applicable

The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels

DLR German Aerospace Center1 site in 1 country11 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle; Atrophy, General
Sponsor
DLR German Aerospace Center
Enrollment
11
Locations
1
Primary Endpoint
Bone density as measured with pQCT
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

11 healthy men used the HEPHAISTOS unloading orthosis in an ambulatory 8 week intervention study.

It greatly reduces calf muscle forces without reducing ground reaction forces.

Detailed Description

The 56day unloading intervention with HEPHAISTOS had the following key objectives: 1. Primary objective: Assessment and evaluation of bone adaptation. 2. Secondary objective: Assessment and evaluation of functional and structural muscular adaptations. 3. Third objective: Assessment and evaluation of functional and structural vascular adaptations. 4. Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
July 2012
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age: 20-45
  • BMI: 20-30

Exclusion Criteria

  • professional sports men
  • rheumatism
  • muscle and joint disease
  • bone fractures within 12 months prior to the study
  • cruciate ligament rupture within 10 years prior to the study
  • metal implants
  • participation in any other clinical study within 2 months prior to the study haemophilia
  • any blood vessel disease
  • claustrophobia
  • herniated disk

Outcomes

Primary Outcomes

Bone density as measured with pQCT

Time Frame: At baseline and up to 12 months after the immobilization phase

Change from baseline to 14 days after immobilization phase

Secondary Outcomes

  • Structural and functional parameters of arterial adaptation(At baseline and up to 12 months after the immobilization phase)

Study Sites (1)

Loading locations...

Similar Trials